TLIS logo

Talis Biomedical Corporation Stock Price

OTCPK:TLIS Community·US$3.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

TLIS Share Price Performance

US$1.84
0.15 (8.88%)
US$1.84
0.15 (8.88%)
Price US$1.84

TLIS Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Talis Biomedical Corporation Key Details

US$408.0k

Revenue

US$20.5m

Cost of Revenue

-US$20.1m

Gross Profit

US$30.9m

Other Expenses

-US$51.0m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-27.99
-4,923.77%
-12,506.37%
0%
View Full Analysis

About TLIS

Founded
2013
Employees
99
CEO
n/a
WebsiteView website
talisbio.com

Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.

Recent TLIS News & Updates

Recent updates

No updates